Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorderJournal of Psychopharmacology · 2026-07-16Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-23Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice.bioRxiv: the preprint server for biology · 2026-04-22Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trialNeuroscience Applied · 2026-01-01Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-16Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.Nature · 2025-10-01Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-03Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01Psilocybin's lasting action requires pyramidal cell types and 5-HT receptors.Nature · 2025-06-01In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025-05-22Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology.bioRxiv: the preprint server for biology · 2025-02-11Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-06The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.Journal of psychiatric research · 2024-12-01Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression.bioRxiv: the preprint server for biology · 2024-11-23Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.Scientific reports · 2024-11-21Pyramidal cell types and 5-HT receptors are essential for psilocybin's lasting drug action.bioRxiv: the preprint server for biology · 2024-11-03Refractory CRPS pain treated with psilocybin: A case report.Clinical case reports · 2024-09-01At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.Social work · 2024-06-21Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptorsbioRxiv · 2024-05-06Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)Journal of Forensic Sciences · 2024-03-01Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometryJournal of Analytical Toxicology · 2024-03-01Psychedelic-like Activity of Norpsilocin Analogues.ACS chemical neuroscience · 2024-01-17Rapid-acting antidepressant drugs modulate affective bias in rats.Science translational medicine · 2024-01-10Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-09-01Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive EffectsJournal of Pharmacology and Experimental Therapeutics · 2023-05-17Unblinding and demand characteristics in the treatment of depression.Journal of affective disorders · 2023-05-01Psychedelic Sensationalism: An Analysis of the Schedule Classification of PsilocybinVanderbilt Undergraduate Research Journal · 2023-04-24Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Psychotherapy with Psilocybin for Depression: Systematic Review.Behavioral sciences (Basel, Switzerland) · 2023-03-31Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-07The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2023-01-01Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trialNeuroscience Applied · 2023-01-01Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS pharmacology & translational science · 2022-11-115-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in micebioRxiv · 2022-11-03Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-29Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related TryptaminesChemBioChem · 2022-07-05Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).ACS omega · 2022-02-15The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta crystallographica. Section C, Structural chemistry · 2022-01-01The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin DimerizationChemistry - A European Journal · 2021-08-19Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of natural products · 2021-04-23Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.ChemPlusChem · 2021-01-01Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-07-14Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-07-02Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-03Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.Journal of natural products · 2020-02-28An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-08Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.Chembiochem: a European journal of chemical biology · 2019-11-18Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.Expert review of clinical pharmacology · 2018-01-01Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.Journal of analytical toxicology · 2007-10-01Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.Behavioural pharmacology · 2004-03-01Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.Journal of Ethnopharmacology · 1982-05-01Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (earle) singerJournal of Ethnopharmacology · 1982-05-01Quantitative analysis of psilocybin and psilocin and psilocybe baecystis (singer and smith) by high-performance liquid chromatography and by thin-layer chromatographyJournal of Chromatography A · 1981-03-01Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic ObservationsJournal of Psychedelic Drugs · 1979-01-01The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neuronsComparative and General Pharmacology · 1972-03-01